Expedition 74 crew members aboard the International Space Station are 3D-printing viable human cartilage tissues inside the Kibo module’s Life Science Glovebox, running a direct test of whether weightlessness produces replacement tissue that holds up better than anything printed on the ground. The work involves thawing cartilage cells, mixing them with bio-ink, loading a cartridge, and printing structures that would collapse under Earth’s gravity without scaffolding. Per NASA crew-activity reports, astronaut Jessica Meir and ESA astronaut Sophie Adenot have both performed bioprinting operations during the current research campaign, which entered a new printing cycle this week.
Why scaffold-free cartilage printing only works in orbit
On Earth, freshly printed biological tissue sags and deforms under its own weight almost immediately. That forces researchers to build temporary scaffold structures around each layer, adding complexity and limiting the shapes they can produce. In microgravity, that constraint disappears. Tissues can grow in three dimensions without collapsing, according to NASA’s ISS Research Integration Office, because there is effectively no downward pull distorting the printed layers during gelation. The practical result is that cells distribute more evenly through the bio-ink matrix as it solidifies, a condition that ground-based labs struggle to replicate even with rotating bioreactors or clinostats.
The hypothesis driving the current Expedition 74 prints is straightforward: if cells settle less during gelation, the extracellular matrix they eventually produce should be more uniform, and the finished tissue should be mechanically stronger. Researchers expect that cartilage printed in true microgravity will show a measurably higher equilibrium modulus after post-flight culture than matched samples printed at normal gravity. The specific threshold being tested has not been publicly disclosed in NASA’s operational reports, but earlier ISS bioprinting work already established the experimental framework for that comparison.
ISS bioprinting results from BFF-Meniscus-2 and peer-reviewed studies
The current Expedition 74 campaign builds on several years of prior station experiments. The BFF-Meniscus-2 investigation used the ISS BioFabrication Facility to 3D print a meniscus, a knee cartilage-like tissue, and directly assessed its mechanical properties against an Earth-printed comparator. That experiment confirmed the feasibility of producing cartilage-scale structures in orbit and returned samples for ground analysis.
By late 2024, NASA’s Johnson Space Center reported that researchers had demonstrated the feasibility of 3D bioprinting meniscus tissue in microgravity, noting that the orbital environment reduced the deformation and collapse that plague Earth-based prints. Those results gave the agency enough confidence to move forward with the more ambitious Expedition 74 cartilage-printing sessions now under way in the Kibo module.
Independent peer-reviewed evidence supports the biological logic behind the effort. A study published in Tissue Engineering Part A compared cartilage tissue formation across three conditions: true microgravity on the ISS, normal 1 g controls, and simulated microgravity. The researchers measured collagen II/I expression ratios along with histological and biochemical endpoints, finding that the gravitational environment altered how cartilage cells organized their matrix. Collagen II is the form most associated with healthy, load-bearing cartilage, so a higher ratio of type II to type I signals tissue that more closely resembles the real thing.
Taken together, these results suggest that microgravity does not just make printing easier. It may change the biology of the printed tissue itself, producing cartilage with a molecular profile closer to what surgeons need for joint repair.
What the Expedition 74 prints still need to prove
The gap between a successful print in orbit and a usable cartilage implant on Earth remains wide. No public primary dataset yet compares the mechanical strength or long-term viability of the current Expedition 74 prints against simultaneous Earth controls. NASA’s status reports describe the workflow in detail, covering bioprinter setup, cell thawing, bio-ink mixing, and printing, but they do not disclose the exact cell sources, bio-ink formulations, or planned post-print culture durations for these latest runs.
Direct statements from lead researchers on molecular endpoints such as collagen ratios or histological scoring remain unavailable for the current campaign. The operational logs published so far are activity reports, not results papers. Until the printed samples return to Earth, undergo culture, and pass through mechanical and biochemical testing, the central question of whether orbit-grown cartilage is genuinely stronger will stay open.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
